DELUCIA DAVID enters KYNTRA BIO, INC. with 118.46K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 12/18/2024ACC: 0001415889-24-029755
Officer· Chief Financial Officer
Since Mar 2026
118.46K
Baseline shares
100% direct
118.46K
Direct ownership
1 position
198.70K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned118.46K
Total
118.46K direct118.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 118.46K | Direct |
| Total | 118.46K | 118.46K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
13.60K
Shares owned
N/A
Exercise price
22.60
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
44K
Shares owned
N/A
Exercise price
1.89
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
100K
Shares owned
N/A
Exercise price
1.21
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
41.10K
Shares owned
N/A
Exercise price
9.99
Expiration
—
Exercise window
—
Total
Underlying
198.70K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 22.60 | — | — | 13.60K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 1.89 | — | — | 44K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 1.21 | — | — | 100K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 9.99 | — | — | 41.10K | N/A |
| Total | 198.70K | 0.00 | ||||